增生平片致肝损害  被引量:11

Zengshengping tablets-induced hepatic damage

在线阅读下载全文

作  者:张俊忠[1] 

机构地区:[1]濮阳市人民医院药剂科,河南濮阳457000

出  处:《药物不良反应杂志》2007年第3期215-215,共1页Adverse Drug Reactions Journal

摘  要:47岁女性患者,因患食管炎服用增生平3片,3次/d,半年后患者出现恶心,黄疸。其TBil122.2μmol/L,DBil108.0μmol/L,ALT581U/L,AST277U/L,GGT125U/L。停服增生平,患者经甘草酸二胺、茵栀黄、肌苷治疗8d后,症状明显好转,实验室检查:TBil94.7μmol/L,DBil81.2μmol/L,ALT162U/L,AST142U/L,GGT125U/L。患者症状明显好转。A 47-year-old women with esophagitis took Zengshengping 3 tablets thrice daily. Six months later, she developed nausea and jaundice, Laboratory tests revealed the following values: TBil 122.2 μmol/L, DBil 108.0 μmol/L, ALT 581 U/L, AST 277 U/L, GGT 125 U/L. The patient's condition improved after withdrawal of the drug and 8 days of treatment with diammonium glycyrrihizinate, Yinzhihuan injection, and inosine tablets. The values of laboratory tests were as follows: TBil 94.7 μmol/L, DBil 81.2 μmol/L, ALT 162 U/L, AST 142 U/L, GGT 125 U/L. Her symptoms improved obviously.

关 键 词:增生平 肝损害 

分 类 号:R286[医药卫生—中药学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象